Cayce Denton
Directeur/Membre du Conseil chez PatientSafe Solutions, Inc.
Profil
Cayce Denton is currently a Director at PatientSafe Solutions, Inc. and Locanabio, Inc. Previously, she held Director positions at Karos Pharmaceuticals, Inc. and Trevi Therapeutics, Inc. She also worked as a Principal at Genentech, Inc. and Novartis Services, Inc. Additionally, she worked as an Investment Banker at Credit Suisse First Boston Corp.
and an Analyst at Atlas Venture Advisors, Inc. She served as a Board Observer at Spark Diagnostics, Inc. and as a Principal at Tarrant Capital IP LLC.
Ms. Denton received her undergraduate degree from Massachusetts Institute of Technology and her MBA from The Wharton School of the University of Pennsylvania.
Postes actifs de Cayce Denton
| Sociétés | Poste | Début |
|---|---|---|
PatientSafe Solutions, Inc.
 PatientSafe Solutions, Inc. Packaged SoftwareTechnology Services PatientSafe Solutions, Inc. provides wireless workflow optimization and patient safety solutions. It designs hardware and software solutions to provide patient safety and improve patient, family, and nurse satisfaction in hospitals. It offers clinical communications and workflows, coordinated care, and professional services. The company was founded by Keith Blei, Gerald E. Forth, David D. Swenson, Pat Steusloff and Kim T. Rubin in 2002 and is headquartered in San Diego, CA. | Directeur/Membre du Conseil | - |
Locanabio, Inc.
 Locanabio, Inc. Packaged SoftwareTechnology Services Locana, Inc. engages in the provision of ribonucleic acid targeting gene therapy. Its platform technology addresses a wide spectrum of human genetic diseases. It has advanced a powerful modular RNA targeting-effector approach to optimize and advance therapeutic candidates that is distinct from DNA-targeted approaches and nucleic acid-based RNA targeting. The company was founded by Gene Yeo and David Nelles in 2016 and is headquartered in San Diego, CA. | Directeur/Membre du Conseil | - |
Anciens postes connus de Cayce Denton
| Sociétés | Poste | Fin |
|---|---|---|
| Credit Suisse First Boston Corp. | Corporate Officer/Principal | - |
| Novartis Services, Inc. | Corporate Officer/Principal | - |
Spark Diagnostics, Inc.
 Spark Diagnostics, Inc. Medical/Nursing ServicesHealth Services Spark Diagnostics, Inc. provides diagnostic services. It uses sequencing technology to diagnose diseases. The company was founded by Jessica Owens in 2011 and is headquartered in San Francisco, CA. | Corporate Officer/Principal | - |
Tarrant Capital IP LLC
 Tarrant Capital IP LLC Investment ManagersFinance Tarrant Capital IP LLC operates as a venture capital firm. It serves the consumer, retail, technology, internet, healthcare, energy, cleantech, digital media, real estate, renewables and transportation industries. The company was founded by David Bonderman and Jim Coulter in 1992 and is headquartered in San Francisco, CA. | Corporate Officer/Principal | - |
Karos Pharmaceuticals, Inc.
 Karos Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Karos Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. The firm focuses on bone related, pulmonary arterial hypertension and other orphan diseases. The company was founded in 2009 and is headquartered in New Haven, CT. | Directeur/Membre du Conseil | - |
Formation de Cayce Denton
| Massachusetts Institute of Technology | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| TREVI THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 9 |
|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Atlas Venture Advisors, Inc.
 Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Finance |
Karos Pharmaceuticals, Inc.
Karos Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Karos Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. The firm focuses on bone related, pulmonary arterial hypertension and other orphan diseases. The company was founded in 2009 and is headquartered in New Haven, CT. | Health Technology |
Tarrant Capital IP LLC
Tarrant Capital IP LLC Investment ManagersFinance Tarrant Capital IP LLC operates as a venture capital firm. It serves the consumer, retail, technology, internet, healthcare, energy, cleantech, digital media, real estate, renewables and transportation industries. The company was founded by David Bonderman and Jim Coulter in 1992 and is headquartered in San Francisco, CA. | Finance |
| Novartis Services, Inc. | |
Spark Diagnostics, Inc.
Spark Diagnostics, Inc. Medical/Nursing ServicesHealth Services Spark Diagnostics, Inc. provides diagnostic services. It uses sequencing technology to diagnose diseases. The company was founded by Jessica Owens in 2011 and is headquartered in San Francisco, CA. | Health Services |
| Credit Suisse First Boston Corp. | Finance |
PatientSafe Solutions, Inc.
PatientSafe Solutions, Inc. Packaged SoftwareTechnology Services PatientSafe Solutions, Inc. provides wireless workflow optimization and patient safety solutions. It designs hardware and software solutions to provide patient safety and improve patient, family, and nurse satisfaction in hospitals. It offers clinical communications and workflows, coordinated care, and professional services. The company was founded by Keith Blei, Gerald E. Forth, David D. Swenson, Pat Steusloff and Kim T. Rubin in 2002 and is headquartered in San Diego, CA. | Technology Services |
Locanabio, Inc.
Locanabio, Inc. Packaged SoftwareTechnology Services Locana, Inc. engages in the provision of ribonucleic acid targeting gene therapy. Its platform technology addresses a wide spectrum of human genetic diseases. It has advanced a powerful modular RNA targeting-effector approach to optimize and advance therapeutic candidates that is distinct from DNA-targeted approaches and nucleic acid-based RNA targeting. The company was founded by Gene Yeo and David Nelles in 2016 and is headquartered in San Diego, CA. | Technology Services |